The Fly | TMCI

Proprietary Lapiplasty System: The company holds patents and intellectual property for its Lapiplasty 3D Bunion Correction System, making it difficult for competitors to replicate its core technology.

Robust Clinical Evidence: Extensive clinical studies and publications demonstrate the efficacy, predictability, and favorable outcomes of the Lapiplasty procedure, building surgeon confidence and adoption.

Dedicated Surgeon Training & Education: TMCI provides comprehensive training programs and educational resources, fostering a skilled base of surgeons proficient in the Lapiplasty technique.

Market Adoption & Competition Risks: Slow market penetration for the Lapiplasty system due to resistance to new surgical techniques, competition from established bunion correction procedures, and the emergence of alternative treatments.

Regulatory Compliance Risks: Maintaining necessary FDA approvals for products, potential for new or stricter regulatory requirements, and the risk of product recalls or safety alerts that could halt sales and damage reputation.

Intellectual Property Risks: Challenges in protecting their proprietary Lapiplasty technologies and instruments, exposure to patent infringement claims from competitors, or the expiration of key patents.

Charts

Dedicated Surgeon Training & Education: TMCI provides comprehensive training programs and educational resources, fostering a skilled base of surgeons proficient in the Lapiplasty technique.